Bristol Myers Squibb Co. (BMY)
54.80
+0.30
(+0.55%)
USD |
NYSE |
Jan 22, 14:38
Bristol Myers Squibb Research and Development Expense (TTM): 9.719B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Gilead Sciences, Inc. | 5.734B |
| Johnson & Johnson | 14.70B |
| Eli Lilly & Co. | 12.56B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |